Doximity reported strong fiscal Q1 2027 results, driving its stock up over 30% intraday. The company is successfully transforming physician searches into a commercial marketplace by leveraging AI to monetize real-time physician intent. This AI integration enhances Doximity's pharmaceutical advertising business by capturing value at the critical point of physician decision-making. The results validate previous bullish views on the company's valuation and growth potential driven by AI innovation.
Yili Group held a sustainability forum on August 2, 2026, during the World Dairy Industry Conference in Hohhot, China, gathering over 200 global leaders to discuss sustainable development in dairy farming beyond 2030. The event highlighted Yili's lea...
Yili Group organized a Sustainability Forum during the 2026 World Dairy Industry Conference in Hohhot, China, gathering over 200 international leaders to promote sustainable development in the dairy sector beyond 2030. The event highlighted Yili's le...
Halper Sadeh LLC is investigating whether shareholders of Beazer Homes USA (BZH), Arcosa (ACA), Synaptics (SYNA), and Crinetics Pharmaceuticals (CRNX) are receiving fair treatment in their companies' recent sales. The law firm suspects insiders may g...
After holding a record $397.4 billion cash pile and selling stocks for 14 consecutive quarters, Berkshire Hathaway has shifted strategy. In Q2 2026, under CEO Greg Abel, the company became a net buyer of stocks again, purchasing about $20 billion mor...
Purepoint Uranium CEO Chris Frostad detailed the critical role of geological interpretation after drill core recovery in refining uranium exploration targets. The process involves analyzing rock types, structures, and radioactivity from drill holes, ...
